Enhancing drug discovery with advanced biophysical insights
Biophysical methods are crucial in the early drug discovery process. Our state-of-the-art biophysical platform can accelerate your discovery programs by providing in-depth analysis of compound–target interactions. We offer fragment screening to identify low-affinity binders in primary hit-finding campaigns and use orthogonal methods for hit validation of compounds from biochemical and cellular assays as well as screening campaigns.
